SG11201608570YA - Humanized il-4 and il-4r alpha animals - Google Patents

Humanized il-4 and il-4r alpha animals

Info

Publication number
SG11201608570YA
SG11201608570YA SG11201608570YA SG11201608570YA SG11201608570YA SG 11201608570Y A SG11201608570Y A SG 11201608570YA SG 11201608570Y A SG11201608570Y A SG 11201608570YA SG 11201608570Y A SG11201608570Y A SG 11201608570YA SG 11201608570Y A SG11201608570Y A SG 11201608570YA
Authority
SG
Singapore
Prior art keywords
humanized
animals
alpha
alpha animals
Prior art date
Application number
SG11201608570YA
Inventor
Li-Hsien Wang
Yingzi Xue
Andrew J Murphy
Sean Stevens
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201608570YA publication Critical patent/SG11201608570YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201608570YA 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals SG11201608570YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07
PCT/US2015/029638 WO2015171861A1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Publications (1)

Publication Number Publication Date
SG11201608570YA true SG11201608570YA (en) 2016-11-29

Family

ID=53284509

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201608570YA SG11201608570YA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals
SG10201912354PA SG10201912354PA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201912354PA SG10201912354PA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Country Status (25)

Country Link
US (7) US9565841B2 (en)
EP (3) EP3281521B1 (en)
JP (4) JP6640740B2 (en)
KR (2) KR102517112B1 (en)
CN (2) CN106470545B (en)
AU (2) AU2015255977B2 (en)
BR (1) BR112016025745A2 (en)
CA (2) CA3207834A1 (en)
CY (2) CY1119773T1 (en)
DK (2) DK3281521T3 (en)
ES (2) ES2887852T3 (en)
HR (2) HRP20211455T1 (en)
HU (2) HUE038028T2 (en)
IL (3) IL248358B2 (en)
LT (2) LT3281521T (en)
MX (1) MX370672B (en)
NO (1) NO2785538T3 (en)
PH (1) PH12016502058A1 (en)
PL (2) PL3281521T3 (en)
PT (2) PT3027015T (en)
RS (2) RS57073B1 (en)
RU (1) RU2703139C2 (en)
SG (2) SG11201608570YA (en)
SI (2) SI3027015T1 (en)
WO (1) WO2015171861A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (en) 2014-05-07 2018-08-04
MX2016016903A (en) 2014-06-19 2017-03-27 Regeneron Pharma Non-human animals having a humanized programmed cell death 1 gene.
ES2946664T3 (en) * 2014-09-17 2023-07-24 Oerlikon Surface Solutions Ag Pfaeffikon Method for producing a double-layer coated cutting tool with improved wear resistance
HUE059417T2 (en) 2014-11-24 2022-11-28 Regeneron Pharma Non-human animals expressing humanized cd3 complex
MX2017007293A (en) 2014-12-05 2018-03-12 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 47 gene.
NZ742447A (en) 2015-11-20 2022-12-23 Regeneron Pharma Non-human animals having a humanized lymphocyte-activation gene 3
JP6843872B2 (en) 2016-02-04 2021-03-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animals carrying the engineered ANGPTL8 gene
SG10202001578RA (en) * 2016-02-29 2020-04-29 Regeneron Pharma Rodents having a humanized tmprss gene
TWI784988B (en) 2016-12-01 2022-12-01 美商再生元醫藥公司 Methods of treating inflammatory conditions
JP7321939B2 (en) 2017-04-13 2023-08-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Treatment and inhibition of inflammatory lung disease in patients with risk alleles in genes encoding IL33 and IL1RL1
WO2018231827A1 (en) 2017-06-12 2018-12-20 Bluefin Biomedicine, Inc. Anti-il1rap antibodies and antibody drug conjugates
US20190098879A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use
CA3076377A1 (en) 2017-11-30 2019-06-06 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized trkb locus
JP7328243B2 (en) 2018-03-26 2023-08-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Humanized rodents for testing therapeutic agents
IL307286A (en) 2018-04-11 2023-11-01 Regeneron Pharma Methods and compositions for quantifying il-33
JP7048051B2 (en) 2018-07-11 2022-04-05 正徳 染井 Atopic dermatitis remedy to reduce itching
CA3098040A1 (en) 2018-07-16 2020-01-23 Regeneron Pharmaceuticals, Inc. Non-human animal models of ditra disease and uses thereof
WO2020074005A1 (en) * 2018-10-12 2020-04-16 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric genes
CN111218425B (en) * 2019-01-17 2022-02-08 百奥赛图(北京)医药科技股份有限公司 Humanized transgenic animal
US11737435B2 (en) 2019-04-04 2023-08-29 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized coagulation factor 12 locus
JP2022534867A (en) 2019-06-04 2022-08-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Non-human animals containing humanized TTR loci with beta slip mutations and methods of use
AU2020289581A1 (en) 2019-06-07 2021-11-18 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
US20220272953A1 (en) * 2019-07-29 2022-09-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il33
WO2021027737A1 (en) * 2019-08-09 2021-02-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
CN112779285B (en) * 2019-11-11 2023-01-06 百奥赛图(北京)医药科技股份有限公司 Construction method and application of humanized IL-10 and IL-10RA gene modified animal
CN114786479B (en) * 2019-12-25 2023-12-15 江苏集萃药康生物科技股份有限公司 IL-15 humanized mouse model and application thereof
WO2021154791A1 (en) * 2020-01-28 2021-08-05 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
CN111149767B (en) * 2020-02-24 2021-07-20 中南大学湘雅二医院 Construction method and application of humanized skin type lupus erythematosus mouse model
CN113527485A (en) * 2020-04-17 2021-10-22 上海麦济生物技术有限公司 Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof
CN111808882B (en) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Construction method and application of IL7R gene humanized modified animal model
CN111793646B (en) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Construction method and application of non-human animal subjected to IL1R1 gene humanization transformation
CN111926039B (en) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Construction method and application of IL-13 gene humanized non-human animal
CN116802200A (en) * 2020-12-21 2023-09-22 瑞泽恩制药公司 Non-human animals with humanized TSLP genes, humanized TSLP receptor genes and/or humanized IL7RA genes
CN114835798B (en) * 2021-05-28 2024-02-23 百奥赛图(北京)医药科技股份有限公司 Construction method and application of CD36 gene humanized non-human animal
WO2024067796A1 (en) * 2022-09-28 2024-04-04 百奥赛图(北京)医药科技股份有限公司 Non-human animal having humanized il5 and/or il5ra gene

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US7294754B2 (en) 2004-10-19 2007-11-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
JP2007252370A (en) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Il-4 initial expression-based transgenic non-human animal and use of the same
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
US20120157667A1 (en) * 2009-06-29 2012-06-21 Qingfeng Chen Methods Of Producing Humanized Non-Human Mammals
JP2013500018A (en) * 2009-07-24 2013-01-07 シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー Methods for genome editing
RU2425880C2 (en) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Method of producing transgene mice
ES2700852T3 (en) 2009-10-06 2019-02-19 Regeneron Pharma Genetically modified and grafted mice
SG10202008003VA (en) 2011-02-15 2020-10-29 Regeneron Pharma Humanized m-csf mice
RU2660564C2 (en) 2011-10-28 2018-07-06 Регенерон Фармасьютикалз, Инк. Genetically modified mice expressing chimeric major histocompatibility complex molecules
LT3262932T (en) 2011-10-28 2019-08-26 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
RS53683B1 (en) * 2011-10-28 2015-04-30 Regeneron Pharmaceuticals Inc. Humanized il-6 and il-6 receptor
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
PT3470432T (en) * 2012-08-21 2021-12-14 Regeneron Pharma Methods for treating or preventing asthma by administering an il-4r antagonist
JP6283031B2 (en) 2012-09-07 2018-02-21 イエール ユニバーシティ Genetically modified non-human animals and uses thereof
CN114766432A (en) 2012-11-05 2022-07-22 再生元制药公司 Genetically modified non-human animals and methods of use thereof
AU2014218897C1 (en) 2013-02-20 2019-03-07 Regeneron Pharmaceuticals, Inc. Mice expressing humanized T-cell co-receptors
LT2958937T (en) 2013-02-22 2018-11-26 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
JO3532B1 (en) 2013-03-13 2020-07-05 Regeneron Pharma Anti-il-33 antibodies and uses thereof
DK3175706T3 (en) 2013-09-23 2019-03-04 Regeneron Pharma Non-human animals with a humanized signal regulatory protein gene
RS58465B1 (en) 2013-10-15 2019-04-30 Regeneron Pharma Humanized il-15 animals
SG10201900003WA (en) 2013-11-19 2019-02-27 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene
US20150143559A1 (en) 2013-11-19 2015-05-21 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
SI3129400T1 (en) 2014-04-08 2020-07-31 Regeneron Pharmaceuticals, Inc. Non-human animals having humanized fc-gamma receptors
MX2016014504A (en) 2014-05-05 2017-05-23 Regeneron Pharma Humanized c5 and c3 animals.
NO2785538T3 (en) 2014-05-07 2018-08-04

Also Published As

Publication number Publication date
CN106470545B (en) 2019-08-20
ES2887852T3 (en) 2021-12-28
CY1124605T1 (en) 2022-07-22
PH12016502058A1 (en) 2017-01-09
JP2021087434A (en) 2021-06-10
EP3027015A1 (en) 2016-06-08
CY1119773T1 (en) 2018-06-27
MX2016014563A (en) 2017-02-23
US11963521B2 (en) 2024-04-23
US10588298B2 (en) 2020-03-17
US20210368753A1 (en) 2021-12-02
CA3207834A1 (en) 2015-11-12
AU2021218060A1 (en) 2021-09-09
EP3906781A1 (en) 2021-11-10
US20200022344A1 (en) 2020-01-23
IL297105B1 (en) 2023-09-01
CN106470545A (en) 2017-03-01
SI3281521T1 (en) 2021-11-30
JP6640740B2 (en) 2020-02-05
US20150320022A1 (en) 2015-11-12
NO2785538T3 (en) 2018-08-04
US20150320021A1 (en) 2015-11-12
HRP20211455T1 (en) 2022-01-07
RU2703139C2 (en) 2019-10-15
KR20220165814A (en) 2022-12-15
IL304841A (en) 2023-09-01
SG10201912354PA (en) 2020-02-27
US10477842B2 (en) 2019-11-19
US11109578B2 (en) 2021-09-07
CA2947307C (en) 2023-09-26
RU2016143376A3 (en) 2018-11-22
US20230027494A1 (en) 2023-01-26
SI3027015T1 (en) 2018-02-28
CN110269047A (en) 2019-09-24
KR102517112B1 (en) 2023-04-03
IL297105A (en) 2022-12-01
WO2015171861A1 (en) 2015-11-12
PL3281521T3 (en) 2022-01-03
JP6838131B2 (en) 2021-03-03
RU2016143376A (en) 2018-06-09
RS57073B1 (en) 2018-06-29
EP3281521A1 (en) 2018-02-14
AU2015255977B2 (en) 2021-09-02
HUE038028T2 (en) 2018-09-28
ES2656529T3 (en) 2018-02-27
DK3281521T3 (en) 2021-09-20
PL3027015T3 (en) 2018-04-30
HUE055860T2 (en) 2021-12-28
CA2947307A1 (en) 2015-11-12
IL297105B2 (en) 2024-01-01
JP7145250B2 (en) 2022-09-30
CN110269047B (en) 2021-11-02
EP3281521B1 (en) 2021-06-30
PT3281521T (en) 2021-09-16
US9743647B2 (en) 2017-08-29
US20180000056A1 (en) 2018-01-04
LT3281521T (en) 2021-09-27
JP2022171841A (en) 2022-11-11
BR112016025745A2 (en) 2018-01-16
AU2015255977A1 (en) 2016-11-17
PT3027015T (en) 2018-02-09
HRP20180242T1 (en) 2018-03-09
EP3027015B1 (en) 2017-11-08
AU2021218060B2 (en) 2024-04-11
IL248358A0 (en) 2016-11-30
IL248358B2 (en) 2023-03-01
US20170311580A1 (en) 2017-11-02
KR102473565B1 (en) 2022-12-02
JP2017514501A (en) 2017-06-08
IL248358B (en) 2022-11-01
MX370672B (en) 2019-12-19
JP2020058379A (en) 2020-04-16
KR20160150637A (en) 2016-12-30
US9565841B2 (en) 2017-02-14
RU2019131253A (en) 2019-12-06
RS62345B1 (en) 2021-10-29
DK3027015T3 (en) 2018-01-22
LT3027015T (en) 2018-01-25

Similar Documents

Publication Publication Date Title
IL297105B1 (en) Humanized il-4 and il-4r alpha animals
IL276946A (en) Antiproliferative compounds and methods of use thereof
IL248481B (en) Humanized c5 and c3 animals
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL284291A (en) Humanized anti-acth antibodies and use thereof
GB201401617D0 (en) Novel combination and use
IL247315A0 (en) Anti-acth antibodies and use thereof
HK1243950A1 (en) Novel combination and use
HK1243077A1 (en) Piperidinylpyrazolopyrimidinones and their use
GB201420805D0 (en) Ligatures and use thereof
PL3229772T3 (en) 6-aryl-9-glycosylpurines and use thereof